- Pharmacologic Cardioversion for Atrial Fibrillation and Flutter. Cayley Jr., William E. // American Family Physician;12/1/2005, Vol. 72 Issue 11, p2217
Presents a clinical case involving pharmacologic cardioversion for atrial fibrillation and flutter. Information on the patient; Discussion on the question of whether or not antiarrhythmic medications should be used to restore sinus rhythm for patients with atrial fibrillation; Explanation that...
- Rate control was not inferior to rhythm control for recurrent persistent atrial fibrillation. // ACP Journal Club;Sep/Oct2003, Vol. 139 Issue 2, p37
Presents a study that compared the effectiveness of rate control with rhythm control in treating persistent atrial fibrillation. Design; Intervention; Outcome measures; Results; Commentary.
- Dronedarone: A New Therapeutic Agent for Atrial Fibrillation. Sandeep Chopra; Dinesh K. Badyal; P. Chris Baby // JK Science;
The article discusses the study on the effectiveness of dronedarone drug for treating atrial fibrillation. It offers information on atrial fibrillation which is a common cardiac arrhythmia, however there is no therapeutic option that is clearly established. It explores the mechanisms of...
- Mechanisms and Catheter Ablation Therapy of Atrial Fibrillation. Morady, Fred // Texas Heart Institute Journal;2005, Vol. 32 Issue 2, p199
Focuses on atrial fibrillation and catheter ablation therapy. Limitations of catheter ablation therapy; Mechanisms that participate in generating atrial fibrillation; Results of a study on patients with atrial fibrillation treated with either a rhythm control strategy or a rate control strategy.
- Cardiac resynchronisation therapy in chronic atrial fibrillation: impact on left atrial size and reversal to sinus rhythm. Kiès, P.; Leclercq, C.; Bleeker, G. B.; Crocq, C.; Molhoek, S. G.; Poulain, C.; van Erven, L.; Bootsma, M.; Zeppenfeld, K.; van der Wall, E. E.; Daubert, J.-C.; Schalij, M. J.; Bax, J. J. // Heart;Apr2006, Vol. 92 Issue 4, p490
Objective: To evaluate the impact of long term cardiac resynchronisation therapy (CRT) on left atrial and left ventricular (LV) reverse remodelling and reversal to sinus rhythm (SR) in patients with heart failure with atrial fibrillation (AF). Patients: 74 consecutive patients (age 68 (8) years;...
- Atrial remodeling in permanent atrial fibrillation: mechanism and implications. Jost, Norbert; Muntean, Danina; Varro, Andras // Cardiologia Croatica;May/Jun2014, Vol. 9 Issue 5/6, p205
Atrial fibrillation (AF) is the most common arrhythmia in the clinical practice. It can occur at any age; however, it becomes extremely common in the elderly, with a prevalence approaching more than 20% in patients older than 85-years. AF is associated with a wide range of cardiac and...
- Rhythm-control strategies were not better than rate-control strategies in atrial fibrillation. Silver, Alan // ACP Journal Club;Sep/Oct2003, Vol. 139 Issue 2, p36
Presents a study that compared the effectiveness of long-term rate-control treatment strategy with a rhythm-control treatment strategy for atrial fibrillation. Design; Intervention; Outcome measures; Results; Commentary.
- New Data Shows Clinical Benefit of Cardiac Resynchronization Therapy in Atrial Fibrillation. // Biomedical Market Newsletter;5/9/2011, p162
The article reports that data presented at Heart Rhythm 2011, the 32nd Annual Scientific Sessions of the Heart Rhythm Society, shows the clinical benefit of cardiac resynchronization therapy (CRT) versus conventional right-ventricle (RV) pacing in improving heart failure (HF) in patients...
- World Atrial Fibrillation Awareness Day - It's About Time! Lakkireddy, Dhanunjaya // JAFIB: Journal of Atrial Fibrillation;
The author reflects on the prevalence of Atrial Fibrillation (AF) which have increased and relatively not common before the age of 60 years affecting 10% of population in the U.S. He states that coronary artery disease happens due to functional stenosis or mechanical obstruction of coronary...